NCT00423527View on ClinicalTrials.gov

Levetiracetam in Central Pain in Multiple Sclerosis(MS)

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Multiple Sclerosis
Interventions
DRUG

levetiracetam

Levetiracetam tablets 500 mg, total daily dose 3000 mg

Trial Locations (1)

DK-5000

Department of Neurology, Odense University Hospital, Odense C

All Listed Sponsors
lead

Odense University Hospital

OTHER

NCT00423527 - Levetiracetam in Central Pain in Multiple Sclerosis(MS) | Biotech Hunter | Biotech Hunter